Appointments at Sproxil, Intercell and Evolva Holding – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Active pharmaceutical ingredient Management occupations

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sproxil, Intercell and Evolva Holding.

Cambridge Major Laboratories​ (CML​) has named Richard Proehl​ as vice president (VP) of manufacturing. Proehl last worked at Coviden where he was responsible for the company’s largest active pharmaceutical ingredient (API) production plant.

Paul Chang​ has joined the board of advisors at anti-counterfeiting firm Sproxil​. Chang is global business strategy lead, emerging technologies at IBM Software Group and joined the company in 2004.

Merck Sharp & Dohme​ (MSD​) has appointed Steve Warner​ as managing director of its Romanian subsidiary. Warner succeeds Agata Jakoncic ​who has been promoted to the regional level.

Thomas Lingelbach ​has been named CEO of Intercell AG ​after Gerd Zettlmeissl ​resigned “to pursue other personal and professional interests​”. Lingelbach joined Intercell as chief operating officer in 2006 and has been involved with manufacturing and product development at Novartis.

Evolva Holding SA​ has hired Norbert Bender​ as chief medical officer. Bender has worked in biopharm companies, including Knoll and ViroLogik, for more than 20 years.

Yanliang Song​ has joined Global Pharm​ as VP in charge of operations in a three year deal. Song has 15 years of pharma experience and has served as general manager at a number of companies.

Aceto ​has elected Salvatore Guccione ​to its board of directors. Guccione is an operating partner at Arsenal Capital Partners and has previously worked at WIL Research Laboratories, Cambrex and International Speciality Products.

Steve Tullman ​has been hired as chairman and CEO of Yaupon Therapeutics​. Tullman was president and CEO of Ception Therapeutics, which Cephalon bought last year, and is the current chairman of Vicept Therapeutics.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more